ATOSSA THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Atossa Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2015 to Q2 2024.
  • Atossa Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 5.55 %, a 71.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 5.55 +2.32 +71.8% Jun 30, 2024
Q1 2024 4.6 +1.48 +47.3% Mar 31, 2024
Q4 2023 3.71 +0.84 +29.3% Dec 31, 2023
Q3 2023 3.55 +1.26 +54.9% Sep 30, 2023
Q2 2023 3.23 +1.23 +61.4% Jun 30, 2023
Q1 2023 3.13 Mar 31, 2023
Q4 2022 2.87 Dec 31, 2022
Q3 2022 2.3 Sep 30, 2022
Q2 2022 2 Jun 30, 2022
Q4 2020 35.5 +27.1 +321% Dec 31, 2020
Q3 2020 13.4 +1.72 +14.8% Sep 30, 2020
Q2 2020 11.9 Jun 30, 2020
Q1 2020 8.63 Mar 31, 2020
Q4 2019 8.43 Dec 31, 2019
Q3 2019 11.6 Sep 30, 2019
Q4 2015 35.2 Dec 31, 2015
Q3 2015 29.8 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.